Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7568282 in Early-stage Parkinson's Disease
NCT07781644Phase 2Not yet recruiting
- Sponsor
- Roche
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of RO7568282 in Parkinson's disease (PD), sponsored by Roche. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
RO7568282
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07781644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781644.